Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Income from Continuing Operations (2024 - 2025)

Carlsmed (CARL) has disclosed Income from Continuing Operations for 2 consecutive years, with 8290000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 77.71% year-over-year to 8290000.0, compared with a TTM value of 16870000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of 29306000.0, down 21.54% over the prior year.
  • Income from Continuing Operations was 8290000.0 for Q4 2025 at Carlsmed, up from 9415000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 5500000.0 in Q2 2025 and bottomed at 9415000.0 in Q3 2025.